Boston Scientific Announces Results for First Quarter 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Boston Scientific (BSX) PT Raised to $21 at Leerink Partners Following Q1
April 29, 2015 8:57 AM EDTLeerink Partners analyst Danielle Antalffy reiterated an Outperform rating and boosted its price target Boston Scientific (NYSE: BSX) price target of $21.00 (from $18.00) following Q1 results and solid 2015 outlook.
Antalffy commented, "Over the last two years, BSX's turnaround story has steadily played out, with new management delivering... More
Boston Scientific (BSX) Reports In-Line Q1 EPS
April 28, 2015 7:01 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.78 billion.
Boston Scientific sees FY2015 EPS of $0.88-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue... More
